E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer

被引：0
|
作者：
Taofeek K. Owonikoko
Joseph Aisner
Xin Victoria Wang
Suzanne E. Dahlberg
Eric H. Rubin
Suresh S. Ramalingam
Murugesan Gounder
Paul Gregory Rausch
Rita S. Axelrod
Joan H. Schiller
机构：
[1] Emory University,Department of Biostatistics
[2] Rutgers Cancer Institute of New Jersey,Department of Biostatistics
[3] Harvard School of Public Health,undefined
[4] Dana–Farber Cancer Institute,undefined
[5] Merck Research Laboratories,undefined
[6] Frederick Memorial Hospital,undefined
[7] Thomas Jefferson University,undefined
[8] University of Texas Southwestern Medical Center,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Small cell; Topoisomerase; Clinical trial; Topotecan; Irinotecan; Sequential administration; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：171 / 180
页数：9
相关论文
共 50 条
  • [41] Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer
    Hong, Y. S.
    Lee, H. R.
    Park, S.
    Lee, S. C.
    Hwang, I. G.
    Park, B-B
    Lee, J.
    Ahn, J. S.
    Ahn, M-J
    Lim, H. Y.
    Park, K.
    BRITISH JOURNAL OF CANCER, 2006, 95 (12) : 1648 - 1652
  • [42] Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer
    Y S Hong
    H R Lee
    S Park
    S C Lee
    I G Hwang
    B-B Park
    J Lee
    J S Ahn
    M-J Ahn
    H Y Lim
    K Park
    British Journal of Cancer, 2006, 95 : 1648 - 1652
  • [43] Alternating Chemotherapy with Amrubicin Plus Cisplatin and Weekly Administration of Irinotecan Plus Cisplatin for Extensive-stage Small Cell Lung Cancer
    Noro, Rintaro
    Yoshimura, Akinobu
    Yamamoto, Kazuo
    Miyanaga, Akihiko
    Mizutani, Hideaki
    Minegishi, Yuji
    Seike, Masahiro
    Kubota, Kaoru
    Kosaihira, Seiji
    Hino, Mitsunori
    Ando, Masahiro
    Nomura, Koichiro
    Okano, Tetsuya
    Kobayashi, Kunihiko
    Uematsu, Kazutsugu
    Gemma, Akihiko
    ANTICANCER RESEARCH, 2013, 33 (03) : 1117 - 1123
  • [44] Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience
    Petrioli, Roberto
    Roviello, Giandomenico
    Laera, Letizia
    Luzzi, Luca
    Paladini, Piero
    Ghiribelli, Claudia
    Voltolini, Luca
    Martellucci, Ignazio
    Bianco, Vincenzo
    Francini, Edoardo
    CLINICAL LUNG CANCER, 2015, 16 (06) : E229 - E234
  • [45] Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
    Spigel, David R.
    Greco, F. Anthony
    Zubkus, John D.
    Murphy, Patrick B.
    Saez, Ruben A.
    Farley, Cindy
    Yardley, Denise A.
    Burris, Howard A., III
    Hainsworth, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1555 - 1560
  • [46] Phase 1b study of ramucirumab in combination with irinotecan plus cisplatin in chemo-naive patients with extensive-stage small-cell lung cancer
    Kenmotsu, Hirotsugu
    Mori, Keita
    Mizuno, Risa
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    LUNG CANCER, 2022, 164 : 39 - 45
  • [47] Phase II Study of Topotecan with Cisplatin in Japanese Patients with Small Cell Lung Cancer
    Hosomi, Yukio
    Shibuya, Masahiko
    Niho, Seiji
    Ichinose, Yukito
    Kiura, Katsuyuki
    Sakai, Hiroshi
    Takeda, Koji
    Kudo, Shinzo
    Eguchi, Kenji
    Matsui, Kaoru
    Masuda, Noriyuki
    Ando, Masahiro
    Watanabe, Koshiro
    ANTICANCER RESEARCH, 2011, 31 (10) : 3449 - 3456
  • [48] Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062
    O'Brien, Mary E. R.
    Konopa, Krzystof
    Lorigan, Paul
    Bosquee, Lionel
    Marshall, Ernest
    Bustin, Frederique
    Margerit, Sabine
    Fink, Christian
    Stigt, Jos A.
    Dingemans, Anne Marie C.
    Hasan, Baktiar
    Van Meerbeeck, Jan
    Baas, Paul
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (15) : 2322 - 2330
  • [49] Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first-line therapy in patients with extensive-stage small cell lung cancer
    Cheng, Ying
    Fan, Yun
    Liu, Xiaoqing
    Liu, Yunpeng
    Liu, Jiwei
    Wang, Dong
    Yu, Yan
    Qin, Shukui
    Liu, Wei
    Huang, Cheng
    Zhang, Helong
    Liang, Jun
    Shi, Jianhua
    Sheng, Lijun
    Yu, Hao
    ONCOLOGY LETTERS, 2019, 17 (05) : 4701 - 4709
  • [50] Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma
    Tas, Faruk
    Derin, Duygu
    Guney, Nese
    Camlica, Hakan
    Aydiner, Adnan
    Topuz, Erkan
    LUNG CANCER, 2007, 57 (01) : 79 - 83
12345